AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Edmund Mickunas named VP regulatory and clinical affairs.
2004 OCT 18 - (NewsRx.com & NewsRx.net) -- Oragenics, Inc., (ONI) has named Edmund Mickunas vice president, regulatory and clinical affairs.
"We are very fortunate to find someone with Ed Mickunas' more than 20 years experience in regulatory affairs and clinical trials management within the biotechnology and pharmaceutical industries," said Chuck Soponis, Oragenics CEO. "His experience covers a broad range of regulatory and compliance issues in both the United States and Europe, as well as specific expertise in the area of dental products. I am pleased to welcome Ed to the Oragenics management team."
Prior to joining Oragenics, Mickunas was an independent consultant offering professional services in the areas of ...
- Examine Pharma Business Management in India as the Pharmia Industry Market is...
- Press release article from: M2 Presswire February 4, 2009 700+ words
...Research and Markets: Examine Pharma Business Management in India as the Pharmia...researchandmarkets.com/research/46a25f/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...
- Research and Markets: Examine Pharma Business Management in India as the Pharma...
- Press release article from: Business Wire February 5, 2009 700+ words
...researchandmarkets.com/research/ef9e33/pharma_business_ma) has announced the addition of the "Pharma Business Management in India" report to...come out with the report titled Pharma Business Management Insight for which an...
- Dabur to expand pharma business thru buys.
- News wire article from: Business Line February 12, 2002 700+ words
...pharma segment, is set to grow its own pharma business through the acquisitions route. With...FMCG company was looking to grow its pharma business through acquisitions and was on the...form of loans, he said. Dabur's pharma business clocked a robust 25 per cent growth...
- CHANGE OF PRESIDENT FOR PERLOS' PHARMA BUSINESS SECTOR.
- News wire article from: Europe Intelligence Wire March 19, 2004 700+ words
...Econ.), President of Perlos' Pharma business sector since 2002, has requested...appointed as the new President of Perlos' Pharma business sector as of April 1, 2004. He is...Corporation, the development of the Pharma business sector will continue in line with...
- India: Bayer to hive off pharma business.
- News wire article from: Business Line August 14, 2000 700+ words
...manufacturing operations of the pharma business will continue to remain with Bayer...investment is envisaged before the pharma business reaches any critical mass and this transfer of the pharma business will ensure that all investments...
- Business Line: Dabur to expand pharma business through buys.
- News wire article from: Chemical Business Newsbase February 12, 2002 700+ words
Dabur India Ltd (Dabur) plans to expand its pharma business through acquisitions and is on the look out for suitable...North America. The company proposes to hive-off its pharma business into an independent company once it attains a critical...
- NPIL COUP NETS PHARMA BIZ OF CI FOR Rs70 CRORE (ICI's pharma business posted...
- Magazine article from: India Business Insight January 26, 2002 700+ words
...contenders who had been negotiating with ICI for months. ICI's pharma business posted sales of Rs69 crore in 2000-2001 and Rs76 crore...one time of sales. The annualised gross profit of ICI's pharma business works out to Rs12 crore for 2001-2002, the same as in...
- Pharma business drives Novartis Q3 sales up.
- News wire article from: Asia Africa Intelligence Wire February 2, 2003 700+ words
...sales stood at Rs 394.94 crore (Rs 355.39). According to the company, the increase in sales was led by its core pharma business, which at Rs 240.2 crore for the nine-month period, grew at 15.6 per cent. Biochemie business recorded a 3.5...
- Pharma Business sold for $6.9 Billion: "BASF to Foucs More Strongly on...
- Press release article from: Business Wire December 15, 2000 700+ words
...presence. This is being supplemented by a growing position in agricultural products and oil and gas." After the sale of its pharma business, BASF will generate more than half of its sales in cyclically resilient operations. BASF achieves more than two-thirds...
- Pure pharma business model approaching the end: Mr K Masuzoe.
- News wire article from: Chemical Business Newsbase September 29, 2008 700+ words
The pure pharma business model (type-P model), a style of business centered on R&D and standalone marketing, is nearing its end, according...
Source: HighBeam Research, Edmund Mickunas named VP regulatory and clinical affairs.